Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: LTRN) | Delayed: 0.68 +0.02 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $ | |||
| Open | $0.67 | 52 Week Low | $ | |||
| Day High | $0.71 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $ | |||
| Volume | 115,719 | |||||
